Skip to main content
Premium Trial:

Request an Annual Quote

WaferGen Misses Deadline for Filing 10-Q

NEW YORK (GenomeWeb News) – WaferGen BioSystems disclosed in a regulatory filing yesterday a delay in filing its second-quarter earnings report as it needs more time to sort through the financial effects of a private placement done in the spring.

The Fremont, Calif.-based firm had until Aug. 15 to file its Form 10-Q with the US Securities and Exchange Commission but said that it needed "additional time to assess and refine valuation estimates of convertible preferred stock, convertible notes, and warrants," issued during the second quarter, and which affects its financial statements for the quarter.

In May, WaferGen entered into definitive agreements to raise $30.4 million in a private placement financing of equity and debt.

It said in its SEC document that it intends to file its Form 10-Q on or before Aug. 20.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.